The European Shortages Monitoring Platform (ESMP) is now live with the full scope of functionalities. This will enable marketing authorisation holders (MAHs) and national competent authorities (NCAs) to directly report information on supply, demand and availability of nationally and centrally authorised medicines during crises and preparedness actions led by EMA’s Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG).
The new release facilitates monitoring and management of critical medicines during public health emergencies and major events and in the context of preparedness activities. It follows the release of the functionalities for routine shortage reporting of centrally authorised medicines for MAHs in November 2024…